Word from our CEO

In the spotlight

All figures from 2022

In the spotlight

Illegale geneesmiddelen

Illegal medicinal products: the FAMHP in the fight against pharmaceutical crime


Unavailable medicines: working towards structural solutions

Databank MPM

Information on medicinal products in the FAMHP’s new medicines database

Non-clinical assessment of new medical products shows how science and societal issues are closely intertwined


The e-PIL project: paper information leaflet gives way to electronic version in hospitals

IVDR advisory board

Towards more harmonisation and quality for in-vitro diagnostics in Europe

Simultaan nationaal wetenschappelijk advies

FAMHP once again spearheads European cooperation by means of the SNSA project

Our results per service

DG PRE vergunning

Directorate General PRE authorisation

DG POST vergunning

Directorate General POST authorisation

DG Inspectie

Directorate General Inspection

Transversal support

Give your opinion about our annual report

The FAMHP is constantly striving to improve and we therefore need your feedback. Please give our annual report a score out of ten for content and design.

FAMHP logo

FAMHP logo

Share via
Copy link
Powered by Social Snap